164081-25-8 (H-丝氨酰亮氨酰异亮氨酰甘氨酰精氨酰亮氨酰-OH,PAR-2 (1-6) (mouse, rat) trifluoroacetate salt H-Ser-Leu-Ile-Gly-Arg-Leu-OH trifluoroacetate salt)

H-丝氨酰亮氨酰异亮氨酰甘氨酰精氨酰亮氨酰-OH;3-(3,4-二氟苯基)丙酸;

H-SER-LEU-ILE-GLY-ARG-LEU-OH;PROTEINASE ACTIVATED RECEPTOR 2 AGONIST PEPTIDE (SLIGRL), MOUSE;SER-LEU-ILE-GLY-ARG-LEU;SLIGRL;PAR-2 AGONIST PEPTIDE (SLIGRL), MOUSE;Coagulation Factor II Receptor-Like 1 (1-6) (Mouse, rat), Proteinase Activated Receptor 2 (1-6) (Mouse, rat), SLIGRL, ThroMbin Receptor-Like 1 (1-6) (Mouse, rat);L-Leucine,L-seryl-L-leucyl-L-isoleucylglycyl-L-arginyl-;PAR-2 (1-6) (mouse, rat);PROTEINASE ACTIVATED RECEPTOR 2 (1-6) (MOUSE, RAT);NCGC00167259-01;PAR2 (1-6) (mouse, rat);164081-25-8;(2S,5S,11S,14S,17S)-17-amino-11-sec-butyl-5-(3-guanidinopropyl)-18-hydroxy-2,14-diisobutyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaoctadecan-1-oic acid;AKOS030525611;(2S)-2-[[(2S)-2-[[2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoic acid;(2S,5S,11S,14S,17S)-17-Amino-11-((S)-sec-butyl)-5-(3-guanidinoPropyl)-18-hydroxy-2,14-diisobutyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaoctadecan-1-oic acid;PAR2 (1-6) (mouse, rat)?;

CNOKQOBEMGIIAH-JYAZKYGWSA-N

1S/C29H55N9O8/c1-7-17(6)23(38-26(43)20(11-15(2)3)36-24(41)18(30)14-39)27(44)34-13-22(40)35-19(9-8-10-33-29(31)32)25(42)37-21(28(45)46)12-16(4)5/h15-21,23,39H,7-14,30H2,1-6H3,(H,34,44)(H,35,40)(H,36,41)(H,37,42)(H,38,43)(H,45,46)(H4,31,32,33)/t17-,18-,19-,20-,21-,23-/m0/s1

O=C([C@H](CC(C)C)NC([C@H](CO)N)=O)N[C@H](C(NCC(N[C@H](C(N[C@H](C(=O)O)CC(C)C)=O)CCC/N=C(\N)/N)=O)=O)[C@@H](C)CC